Author

Alba Pérez

Observed name: A. Pérez

Institution: Grifols (Spain)

Observed institution: Grifols (Spain)

ORCID: 0009-0005-9872-7893

Observed ORCID: 0009-0005-9872-7893

OpenAlex ID: A5030909299

Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer’s Disease Patients

2018 · Montserrat Costa, Raquel Horrillo, et al. · Journal of Alzheimer s Disease · 45

Non‐additive effect on thrombin generation when a plasma‐derived factor VIII/von Willebrand factor (FVIII/VWF) is combined with emicizumab in vitro

2020 · María Isabel Bravo, Aida Raventós, et al. · Journal of Thrombosis and Haemostasis · 23

Effect of plasma exchange with albumin replacement on albumin functionality and organ dysfunction in acute-on-chronic liver failure

2024 · Javier Fernández, Miquel Lozano, et al. · JHEP Reports · 17

Albumin Oxidation Status in Sepsis Patients Treated With Albumin or Crystalloids

2021 · Matteo Bonifazi, Jennifer Meessen, et al. · Frontiers in Physiology · 15

Cross-Sectional Characterization of Albumin Glycation State in Cerebrospinal Fluid and Plasma from Alzheimer's Disease Patients

2019 · Montserrat Costa, A. Mestre, et al. · The Journal of Prevention of Alzheimer s Disease · 8

Plasma‐derived FVIII/VWF complex shows higher protection against inhibitors than isolated FVIII after infusion in haemophilic patients: A translational study

2022 · Maria Isabel Bravo, Alba Pérez, et al. · Haemophilia · 3

Ex vivo evaluation of the effect of plasma-derived factor VIII/von Willebrand factor in patients with severe hemophilia A on emicizumab prophylaxis

2024 · Aida Raventós, Elena G. Arias-Salgado, et al. · Clinical and Experimental Medicine · 2

Ex Vivo Evaluation of the Effect of Plasma-Derived Factor VIII/Von Willebrand Factor in Patients with Severe Hemophilia_A on Prophylaxis with Emicizumab By Thrombin Generation Assay

2021 · Maria-Isabel Bravo, Aida Raventós, et al. · Blood

Combination of emicizumab and factor VIII has no additive effects after reaching normal coagulation levels

2021 · Maria‐Isabel Bravo, Aida Raventós, et al. · Journal of Thrombosis and Haemostasis

P3‐177: RELATIONSHIP OF ALBUMIN GLYCATION WITH Aβ42 AND TAU BIOMARKERS IN CSF FROM ALZHEIMER'S DISEASE PATIENTS AND HEALTHY CONTROLS

2019 · Montserrat Costa, Anna Mestre, et al. · Alzheimer s & Dementia

P3‐240: Albumin Oxidation in Csf From Alzheimer's Disease Patients Is Associated With Abeta‐42 and Tau Biomarkers and Apoe Genotype

2018 · Montserrat Costa, Raquel Horrillo, et al. · Alzheimer s & Dementia

[P2–257]: ALBUMIN OXIDATION STATUS IN CSF AND PLASMA SAMPLES FROM ALZHEIMER's DISEASE PATIENTS

2017 · Ana Maria Ortiz, Alba Pérez, et al. · Alzheimer s & Dementia

P2‐067: Modifications in Albumin Molecular Profile in a Phase 2 Study Based on Therapeutic Plasma Exchange and 5% Albumin Replacement in Alzheimer's Disease

2016 · Montserrat Costa, Ana María Ortiz, et al. · Alzheimer s & Dementia

Works count: 13

Citation count: 113

H-index: 5

I10-index: 4